Optura has raised $17.5 million in a Series A funding round led by Salesforce Ventures, with participation from Echo Health Ventures and continued investment from Susa Ventures, Matrix Partners and HC9 Ventures, according to a media release issued May 14. The company said the new financing brings its total funding to more than $25 million.
The company said its platform is designed to help healthcare organizations assess the business value of AI initiatives, prioritize investments and measure enterprise impact and return on investment in real time.
In the release, Optura Co-Founder and CEO Andy Fanning said the rapid growth of AI use cases and foundational healthcare models has increased both spending and risk for provider and payer organizations. He said healthcare leaders often lack an objective framework to evaluate AI investments and measure ROI.
Optura cited industry figures showing healthcare organizations are expected to spend more than $18 billion on AI this year, representing 46% of all healthcare investment, while noting that many enterprise generative AI pilots have failed to produce measurable value.
“Healthcare organizations are under growing pressure to move beyond AI experimentation and deliver measurable business outcomes,” Katie Thiry, managing director at Salesforce Ventures, said in the release.
Founded last year, Optura said it has gained traction with organizations including Independence Blue Cross, Prime Therapeutics and Ardent Health. The company said more than $2 billion in AI initiatives are currently loaded into its platform, with $120 million in tracked value and more than 250 identified use cases.
According to the release, the new funding will support expansion of Optura’s AI capabilities, growth of its platform teams and scaling of large language model partnerships.
